
Fexofenadine (120mg) + Montelukast (10mg)
Active composition
+1 more active ingredient
Fexofenadine selectively antagonizes H1 histamine receptors, inhibiting the effects of histamine in allergic reactions.
Montelukast selectively antagonizes leukotriene receptors, inhibiting their effects on bronchoconstriction and inflammation.
Medical applications
Monteblist-F Tablet is a combination medication containing Montelukast 10mg and Fexofenadine 120mg. It is indicated for the relief of symptoms associated with chronic idiopathic urticaria (CIU) and allergic rhinitis. Montelukast, an leukotriene receptor antagonist, inhibits the cysteinyl leukotriene-mediated bronchoconstriction and inflammation, thereby reducing the severity of symptoms. Fexofenadine, a histamine H1 receptor antagonist, blocks the peripheral and central effects of histamine, alleviating symptoms such as nasal congestion, sneezing, and pruritus. This combination medication provides a comprehensive approach to managing the symptoms of CIU and allergic rhinitis. The tablet is designed for oral administration and should be taken once daily. It is contraindicated in patients with hypersensitivity to either montelukast or fexofenadine. As with all medications, patients should be advised to report any unusual symptoms or side effects to their healthcare provider. Monteblist-F Tablet is a valuable treatment option for patients experiencing persistent and debilitating symptoms of CIU and allergic rhinitis.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Monteblist-F Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Monteblist-F Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Medical Advice
Monteblist-F Tablet should be used with caution in patients with kidney disease. Dose adjustment of Monteblist-F Tablet may be needed. Please consult your doctor. May cause excessive sleepiness in patients with end stage kidney disease.
Exercise Caution
Monteblist-F Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Monteblist-F Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Monteblist-F Tablet may not be needed in these patients. Please consult your doctor.
Regular Checkup
0 reviews for Monteblist-F Tablet

Montelukast (10mg) + Fexofenadine (120mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Fexofenadine selectively antagonizes H1 histamine receptors, inhibiting the effects of histamine in allergic reactions.
Montelukast selectively antagonizes leukotriene receptors, inhibiting their effects on bronchoconstriction and inflammation.
Medical applications
Monteblist-F Tablet is a combination medication containing Montelukast 10mg and Fexofenadine 120mg. It is indicated for the relief of symptoms associated with chronic idiopathic urticaria (CIU) and allergic rhinitis. Montelukast, an leukotriene receptor antagonist, inhibits the cysteinyl leukotriene-mediated bronchoconstriction and inflammation, thereby reducing the severity of symptoms. Fexofenadine, a histamine H1 receptor antagonist, blocks the peripheral and central effects of histamine, alleviating symptoms such as nasal congestion, sneezing, and pruritus. This combination medication provides a comprehensive approach to managing the symptoms of CIU and allergic rhinitis. The tablet is designed for oral administration and should be taken once daily. It is contraindicated in patients with hypersensitivity to either montelukast or fexofenadine. As with all medications, patients should be advised to report any unusual symptoms or side effects to their healthcare provider. Monteblist-F Tablet is a valuable treatment option for patients experiencing persistent and debilitating symptoms of CIU and allergic rhinitis.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Monteblist-F Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Monteblist-F Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Medical Advice
Monteblist-F Tablet should be used with caution in patients with kidney disease. Dose adjustment of Monteblist-F Tablet may be needed. Please consult your doctor. May cause excessive sleepiness in patients with end stage kidney disease.
Exercise Caution
Monteblist-F Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Monteblist-F Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Monteblist-F Tablet may not be needed in these patients. Please consult your doctor.
Regular Checkup
0 reviews for Monteblist-F Tablet















